Phospho-CDK2(T160) Polyclonal Antibody

Phospho-CDK2(T160) Polyclonal Antibody

Introducing the PHOSPHO-CDK2(T160) Polyclonal Antibody, a cutting-edge scientific tool designed to facilitate accurate and reliable detection of phosphorylated cyclin-dependent kinase 2 (CDK2) at threonine residue 160. This meticulously crafted antibody is meticulously developed using state-of-the-art techniques, ensuring exceptional specificity and sensitivity in detecting the phosphorylated form of CDK2.

The PHOSPHO-CDK2(T160) Polyclonal Antibody is meticulously produced through a rigorous process, starting with the careful selection of high-quality immunogens. These immunogens are strategically designed to elicit a robust immune response, resulting in the generation of highly specific antibodies targeting the phosphorylated CDK2 at threonine residue 160.

This antibody exhibits exceptional performance in various applications, including Western blotting, immunoprecipitation, and immunohistochemistry. Its superior specificity enables precise identification and quantification of phosphorylated CDK2, facilitating comprehensive investigations into cell cycle regulation, proliferation, and various disease states.

The PHOSPHO-CDK2(T160) Polyclonal Antibody is meticulously validated to ensure consistent and reliable results. Rigorous quality control measures are implemented throughout the production process, guaranteeing batch-to-batch consistency and reproducibility. This antibody demonstrates minimal cross-reactivity with non-phosphorylated CDK2, ensuring accurate and specific detection of the phosphorylated form.

With its exceptional sensitivity, this antibody allows for the detection of low-abundance phosphorylated CDK2, enabling researchers to explore intricate signaling pathways and unravel the complexities of cellular processes. Its robust performance and reliability make it an indispensable tool for scientists and researchers in the fields of molecular biology, biochemistry, and cell biology.

In summary, the PHOSPHO-CDK2(T160) Polyclonal Antibody represents a breakthrough in scientific research, offering unparalleled specificity, sensitivity, and reliability in the detection of phosphorylated CDK2 at threonine residue 160. With its meticulous development and rigorous validation, this antibody is poised to revolutionize investigations into cell cycle regulation, proliferation, and disease mechanisms.